A non-organic intelligent system has for the first time designed, planned and executed a chemistry experiment, Carnegie Mellon University researchers report in the Dec. 21 issue of the journal Nature.
“We anticipate that intelligent agent systems for autonomous scientific experimentation will bring tremendous discoveries, unforeseen therapies and new materials. While we cannot predict what those discoveries will be, we hope to see a new way of conducting research given by the synergetic partnership between humans and machines,” the Carnegie Mellon research team wrote in their paper.
In quantum mechanics, particles can exist in multiple states at the same time, defying the logic of everyday experiences. This property, known as quantum superposition, is the basis for emerging quantum technologies that promise to transform computing, communication, and sensing. But quantum superpositions face a significant challenge: quantum decoherence. During this process, the delicate superposition of quantum states breaks down when interacting with its surrounding environment.
To unlock the power of chemistry to build complex molecular architectures for practical quantum applications, scientists need to understand and control quantum decoherence so that they can design molecules with specific quantum coherence properties. Doing so requires knowing how to rationally modify a molecule’s chemical structure to modulate or mitigate quantum decoherence.
To that end, scientists need to know the “spectral density,” the quantity that summarizes how fast the environment moves and how strongly it interacts with the quantum system.
“Even now, quantum systems can serve as scientific tools,” Oliver Dial, IBM Quantum CTO told IE in an interview. Quantum utility might already be here, but will we soon see a company achieve quantum advantage?
DNA is the building block of life, and the genetic alphabet comprises just four letters or nucleotides. These biochemical building blocks comprise all types of DNA, and scientists have long wondered whether creating working artificial DNA would be possible. Now, a breakthrough may finally provide the answer.
The main goal of a new study, the findings of which were published in Nature Communications this month, shows that scientists may finally be able to create new medicines for certain diseases by creating DNA with new nucleotides that can create custom proteins.
Being able to create artificial DNA could open the door for several important uses. Being able to expand the genetic code could very well diversify the “range of molecules we can synthesize in the lab,” the study’s senior author Dong Wang, Ph.D., explained (via Phys.org).
Much like the humans that created them, computers find physics hard, but quantum mechanics even harder. But a new technique created by three University of Chicago scientists allows computers to simulate certain challenging quantum mechanical effects in complex electronic materials with far less effort.
By making these simulations more accurate and efficient, the scientists hope the technique could help discover new molecules and materials, such as new types of solar cells or quantum computers.
“This advance holds immense potential for furthering our understanding of molecular phenomena, with significant implications for chemistry, material science, and related fields,” said scientist Daniel Gibney, a University of Chicago Ph.D. student in chemistry and first author on the paper, published Dec. 14 in Physical Review Letters.
A team of researchers led by Professor Young S. Park at UNIST’s Department of Chemistry has achieved a significant breakthrough in the field of organic semiconductors. Their successful synthesis and characterization of a novel molecule called “BNBN anthracene” has opened up new possibilities for the development of advanced electronic devices.
The paper is published in the journal Angewandte Chemie International Edition.
Organic semiconductors play a crucial role in improving the movement and light properties of electrons in carbon-centered organic electronic devices. The team’s research focused on enhancing the chemical diversity of these semiconductors by replacing carbon-carbon (C−C) bonds with isoelectronic boron-nitrogen (B−N) bonds. This substitution allows for precise modulation of the electronic properties without significant structural changes.
Kaiserslautern physicists in the team of Professor Dr. Herwig Ott have succeeded for the first time in directly observing pure trilobite Rydberg molecules. Particularly interesting is that these molecules have a very peculiar shape, which is reminiscent of trilobite fossils. They also have the largest electric dipole moments of any molecule known so far.
The researchers used a dedicated apparatus that is capable of preparing these fragile molecules at ultralow temperatures. The results reveal their chemical binding mechanisms, which are distinct from all other chemical bonds. The study was published in the journal Nature Communications.
For their experiment, the physicists used a cloud of rubidium atoms that was cooled down in an ultra-high vacuum to about 100 microkelvin—0.0001 degrees above absolute zero. Subsequently, they excited some of these atoms into a so-called Rydberg state using lasers. “In this process, the outermost electron in each case is brought into far-away orbits around the atomic body,” explains Professor Herwig Ott, who researches ultracold quantum gases and quantum atom optics at University of Kaiserslautern-Landau.
View show notes here: https://bit.ly/3GJjQKz Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter’s email newsletter: https://peterattiamd.com/newsletter/ Colleen Cutcliffe is an expert in molecular biology and co-founder of Pendulum Therapeutics, a company working to develop treatments for a variety of diseases by targeting the microbiome. In this episode, Colleen delves into the complexity of the microbiome, how it is tested, and how it changes over time. She explores how probiotics, prebiotics, and postbiotics affect the gut and makes a compelling case that well-developed products have the potential not only to enhance gut health but also to positively influence overall metabolic well-being. Colleen emphasizes the significance of a high-fiber diet in sustaining a thriving gut microbiome, shares insights on minimizing microbiome damage during antibiotic use, provides tips for fostering and preserving a healthy gut, and much more. We discuss: 0:00:00 — Intro 0:00:34 — Colleen’s background and current focus 0:03:08 — The basics of the microbiome 0:12:37 — The study of the human microbiome 0:17:42 — Categories of bacteria, and the implications on health of the rapid evolution of bacteria 0:27:51 — Methods for measuring and understanding the microbiome, and key indicators of microbiome health 0:39:52 — The important role of fiber for promoting gut health through the production of butyrate 0:47:21 — The case for manipulating gut bacteria via fecal microbiota transplant (FMT) 0:53:25 — Dynamics of the microbiome: the gut-brain connection and how antibiotics, nutrition, stress, and more impact the microbiome’s diversity and function 0:59:16 — Factors that influence the vaginal microbiom 1:03:46 — The effect of gut microbes on obesity and challenges with fecal transplants in people 1:06:25 — Beneficial strains of gut bacteria and strains commonly found in probiotics 1:16:35 — The difference between a probiotic and prebiotic, and how CFUs are a measure of the “active ingredient” 1:21:47 — Considerations about how probiotic strains are produced, and more on the meaning of CFU 1:31:12 — Mitigating the effect of antibiotics on the microbiome 1:39:58 — What do we know about the effect of artificial sweeteners on the gut microbiome? 1:47:02 — Why Akkermansia is a keystone strain with implications for metabolic health and an individual’s response to dietary interventions 1:58:14 — The essential steps necessary to develop a robust probiotic for optimal health support 2:01:45 — How Akkermansia helps control blood glucose, and potential implications of Akkermansia in weight loss, diabetes management, and more 2:22:46 — Pendulum Therapeutics’ commitment to rigorous product develop 2:29:54 — Details about the probiotic “Glucose Control” and other probiotics developed by Pendulum Therapeutics 2:38:43 — Further studies of Akkermansia that have been proposed or are underway ——– About: The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 70 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more. Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan.
Companies and countries are in a race to develop quantum computers. The machines could revolutionize problem solving in medicine, physics, chemistry and engineering.
